S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00945815 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: epratuzumab
DRUG: clofarabine
DRUG: cytarabine
OTHER: laboratory biomarker analysis

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]